Tyrosyl DNA phosphodiesterase 1 (Tdp1) is a promising target for cancer treatment [1,2,3,4] because it plays a key role in removing DNA damage formed by camptothecin group compounds (irinotecan and topotecan), widely used in anticancer therapy [5,6]. Here, TDP1 is linked to cancer.